Atlas Trials

Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy

Clinical trial NCT07243288 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07243288
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Pancreatic CancerMeSH Term-Pancreatic Cancer, Adult)
Start date
2024-01-09
Primary completion
2025-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.